DrugPipeline.net has announced the addition of “Global Cancer Immunotherapies Market 2016-2020” research report to their website DrugPipeline.net

Bangalore, Karnataka -- (SBWire) -- 05/09/2016 --Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies have fewer side effects and can treat different types of cancer. Cancer immunotherapies make up nearly 50% of the cancer drugs market.

Report forecast the global cancer immunotherapies market to grow at a CAGR of 15.17% during the period 2016-2020.

The report covers the present scenario and the growth prospects of the global cancer immunotherapies market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of cancer immunotherapies used to treat cancer.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Global Cancer Immunotherapies Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Amgen
- Bristol-Myers Squibb
- F. Hoffmann-La Roche
- GlaxoSmithKline
- Merck
- Takeda Pharmaceuticals

Other prominent vendors
- AbbVie
- ADC Therapeutics
- Agensys
- Astellas
- AstraZeneca
- Bayer
- Biogen
- Biotech Pharmaceutical
- Boehringer-Ingelheim
- Celgene
- Celldex Therapeutics
- Chugai Pharmaceutical
- CTI Biopharma
- Daiichi Sankyo
- Eli Lilly
- Fortress Biotech
- Genmab
- Immunomedics
- Intas Pharmaceuticals
- Janssen Biotech
- Kyowa Hakko Kirin
- MedImmune
- Morphotek
- Neovii Biotech
- Novartis
- OncoMed Pharmaceuticals
- Pfizer
- Sanofi
- Seattle Genetics
- Spectrum Pharmaceuticals
- TG Therapeutics
- XBiotech

Market driver
- Increase in demand for cancer monoclonal antibodies
- For a full, detailed list, view our report

Market challenge
- Patent expiry of top-selling drugs
- For a full, detailed list, view our report

Market trend
- Emergence of targeted and combination therapies
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 121 pages "Global Cancer Immunotherapies Market 2016-2020" report covers Executive summary, Scope of the report, Market research methodology, Introduction, Overview of cancer immunotherapies, Pipeline portfolio, Market landscape, Market segmentation by type, Geographical segmentation, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Appendix.

For more information Visit at: http://www.drugpipeline.net/technavio/global-cancer-immunotherapies-market-2016-2020

Related Reports:

Global Facial Aesthetics Market 2016-2020; visit - http://www.drugpipeline.net/technavio/global-facial-aesthetics-market-2016-2020

Global Alpha-1 Antitrypsin Drugs Market 2016-2020; visit - http://www.drugpipeline.net/technavio/global-alpha-1-antitrypsin-drugs-market-2016-2020

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.